GV

Encoded Therapeutics adds Dr David Schenkein to its Board as Observer along with raising $135m Series D financing led by GV

– USA, CA –  Encoded Therapeutics, Inc., a precision gene therapy company, today announced it has raised $135 million in an oversubscribed Series D financing led by GV with participation from Matrix Capital Management, ARCH Venture Partners, Illumina Ventures, RTW Investments, Boxer Capital, Nolan Capital, HBM Genomics, Menlo Ventures, Meritech Capital, Farallon Capital Management, SoftBank Vision Fund 21, and additional unnamed investors.…

Scandit raised $30m in Series B funding led by GV

– SWITZERLAND, Zurich – Scandit, the leading enterprise technology platform for mobile computer vision, barcode scanning, and augmented reality, today announced that it has raised $30 million in Series B funding led by GV, with participation from NGP Capital and existing investor Atomico, among others.…

SambaNova Systems adds Lip-Bu Tan and Dave Munichiello to Board along with $56m Series A funding co-led by Walden International and GV

– USA, CA – SambaNova Systems, a Palo-Alto-based startup developing next-generation computing platforms to power machine learning and data analytics applications, today emerged from stealth and announced $56 million in Series A funding led by Walden International and GV with participation from Redline Capital and Atlantic Bridge Ventures.…

Talent4Boards
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.